Results from phase 1 dose escalation study of the proteasome inhibitor NPI-0052 in patients with solid tumors and lymphomas Meeting Abstract
| Authors: | Kurzrock, R.; Hamlin, P.; Younes, A.; Hong, D.; Gordon, M.; Hannah, A.; Palladino, M. A.; Lloyd, G. K.; Longenecker, A. M.; Neuteboom, S. T. C.; Cropp, G. F.; Spears, M. A.; Aghajanian, C. |
| Abstract Title: | Results from phase 1 dose escalation study of the proteasome inhibitor NPI-0052 in patients with solid tumors and lymphomas |
| Meeting Title: | AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2007 Oct 22-26 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2007-12-01 |
| Start Page: | 3433S |
| Language: | English |
| ACCESSION: | WOS:000251969000304 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: B1 - Poster Presentation - Part 2 - "Source: Wos" |
MSK Authors
-
277Hamlin -
607Aghajanian